ANEUVO
PrivateLast Round
Series C
Mar 5, 2026
Total Funding Raised
$30.37M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ANEUVO operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a Series C round in March 2026.
ANEUVO is a medical technology company that develops bioelectronic medicine and non-invasive neuromodulation devices to treat disabling injuries and conditions such as spinal cord injuries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ANEUVO Comparables
Compare ANEUVO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ONWARD Medical N.V. | 87% | |
| SpineX Inc. | 84% | |
| Soterix Medical | 72% |
For institutional investors. Book with your work email.
ANEUVO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 5, 2026 | ||||
| Grant | Oct 28, 2021 | ||||
| Grant | Sep 7, 2021 | ||||
| Series A | Oct 23, 2018 | ||||
| Grant | Dec 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ANEUVO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCLA Innovation Fund | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 33, 2.4x the trailing average.
- Jul 25, 2026
Monthly visitors increased 51% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingAug 19, 2026
ANEUVO International is developing revolutionary bioelectronic medicine to help restore functional independence and improve quality of life for people living with disabling diseases and conditions.
For institutional investors. Book with your work email.
ANEUVO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ANEUVO's valuation, stock price, and market status.
Is ANEUVO a public or private company?
ANEUVO is a private company.
What is the current stock price of ANEUVO?
ANEUVO is a private company, so its shares have no public market price. Caplight tracks ANEUVO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ANEUVO worth (valuation)?
Valuation information for ANEUVO is not publicly available.
Can I buy ANEUVO stock?
ANEUVO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ANEUVO's last funding round?
ANEUVO's most recent funding round was Series C on March 5, 2026.
Who are the main investors in ANEUVO?
Key investors in ANEUVO include UCLA Innovation Fund, National Science Foundation.
Will ANEUVO IPO soon?
No public IPO plans have been announced for ANEUVO.
How can I track ANEUVO secondary market activity?
Caplight tracks bids, offers, and trades in ANEUVO's shares on secondary markets.